A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
Recruiting · NCT06678659 · Registry updated 2026-08-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-08-20 | NCT06678659 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Recursion Pharmaceuticals Inc. | 3 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City of Hope | Duarte | United States | 238 |
| Cleveland Clinic | Cleveland | United States | 558 |
| McGill University Health Centre (MUHC) - The Montreal | Québec | Canada | 1 |
| Princess Margaret Cancer Centre | Toronto | Canada | 9 |
| Sarcoma Oncology Research Center | Santa Monica | United States | 9 |
| SCRI Oncology Partners - PPDS | Nashville | United States | 2 |
| START Mountain Region | West Valley City | United States | 46 |